| ISSN |
1949-8470 (online) |
| Open Access |
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2016. Published by Baishideng Publishing Group Inc. All rights reserved.
|
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Systematic Reviews |
| Article Title |
Role of molecular imaging in the management of patients affected by inflammatory bowel disease: State-of-the-art
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Federico Caobelli, Laura Evangelista, Natale Quartuccio, Demetrio Familiari, Corinna Altini, Angelo Castello, Mariapaola Cucinotta, Rossella Di Dato, Cristina Ferrari, Aurora Kokomani, Iashar Laghai, Riccardo Laudicella, Silvia Migliari, Federica Orsini, Salvatore Antonio Pignata, Cristina Popescu, Erinda Puta, Martina Ricci, Silvia Seghezzi, Alessandro Sindoni, Martina Sollini, Letterio Sturiale, Anna Svyridenka, Vittoria Vergura and Pierpaolo Alongi; Young AIMN Working Group |
| Funding Agency and Grant Number |
|
| Corresponding Author |
Dr. Federico Caobelli, MD, FEBNM, Department of Nuclear Medicine, Universitätsspital Basel, Petersgraben 4, CH-4032 Basel,
Switzerland. federico.caobelli@usb.ch
|
| Key Words |
White blood cell scintigraphy; Inflammatory bowel disease; Inflammation; 18F-Fluorodehoxiglucose positron emission tomography/computed tomography; Molecular imaging |
| Core Tip |
Inflammatory bowel disease (IBD) is a chronic granulomatous inflammatory condition, in which the integrity of the gut epithelium represents a major patho-physiological step. Although endoscopy and barium radiological examinations are the diagnostic “gold stan-dard” for IBD, both techniques require a specific patient preparation, not always feasible or easily tolerated. Molecular imaging with single photon emission tomo-graphy and positron emission tomography seems to be a reliable, non-invasive, accurate and easily reproducible diagnostic tool, able to assess location, extent and activity grade of IBD. We here present the current state-of-the art of molecular imaging in the management of patients affected by IBD. |
| Publish Date |
2016-10-27 17:17 |
| Citation |
Caobelli F, Evangelista L, Quartuccio N, Familiari D, Altini C, Castello A, Cucinotta M, Di Dato R, Ferrari C, Kokomani A, Laghai I, Laudicella R, Migliari S, Orsini F, Pignata SA, Popescu C, Puta E, Ricci M, Seghezzi S, Sindoni A, Sollini M, Sturiale L, Svyridenka A, Vergura V, Alongi P; Young AIMN Working Group. Role of molecular imaging in the management of patients affected by inflammatory bowel disease: State-of-the-art. World J Radiol 2016; 8(10): 829-845 |
| URL |
http://www.wjgnet.com/1949-8470/full/v8/i10/829.htm |
| DOI |
http://dx.doi.org/10.4329/wjr.v8.i10.829 |
